Itchy Skin on Wegovy: How to Tell What's Causing It

Itching around the injection site is one of the most common skin reactions to Wegovy, usually settling within a day or two of each dose.
A widespread, persistent or worsening itch — especially with rash, swelling, or breathing difficulty — needs urgent medical attention as it may indicate a serious allergic reaction.
Itchy skin away from the injection site can have other causes related to treatment, including dry skin from reduced food and fluid intake, or a systemic response to the medicine.
Any unexpected or severe skin symptom while on a GLP-1 medicine can be reported to the MHRA via the Yellow Card scheme.

Itchy skin is reported by some people taking Wegovy (semaglutide), and the cause matters more than the symptom itself. For most, it is mild and short-lived, linked to the injection site or the body adjusting to treatment. In a small number of cases, itching signals something the prescriber needs to know about promptly. The semaglutide medicines page on the NHS lists injection-site reactions among the recognised side effects of this prescription-only medicine, and understanding which type of itch you are experiencing helps you make the right call.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Working out the cause, and what to do next

Is the itch at the injection site, or somewhere else?

This is the first question worth asking, because the answer steers you in very different directions. Localised redness, mild swelling or itching precisely where you injected Wegovy is common and generally harmless. The pre-filled pen delivers semaglutide into the layer of fat beneath the skin, and some immune response at that spot is a normal tissue reaction. The NHS medicines guidance on semaglutide lists injection-site reactions explicitly as a recognised side effect, alongside the more familiar gastrointestinal ones like nausea and indigestion.

Rotating your injection site between the abdomen, thigh and upper arm can reduce repeated irritation in one area. Using a fresh needle each time, letting the pen warm a few minutes before injecting, and avoiding broken or recently irritated skin all lower the chance of a local reaction. The discomfort, when it does appear, typically fades within 24 to 48 hours.

Itching that spreads well beyond the injection site is a different matter. If you notice a rash or hives across your torso, face or limbs shortly after a dose, that warrants a call to your prescriber or GP the same day. Read more about the full range of skin responses in our overview of whether semaglutide causes itchy skin.

When semaglutide and itchy skin points to something more serious

Serious allergic reactions to semaglutide are uncommon, but they are real and documented. The signal to take seriously is itching that arrives alongside swelling of the face, throat or tongue, difficulty breathing, a fast or irregular heartbeat, or a sudden drop in how you feel generally. This combination (not mild injection-site redness) is the pattern that constitutes anaphylaxis. Call 999 or go to A&E immediately.

Short of that emergency scenario, there are other skin presentations worth raising with a clinician rather than waiting out. A widespread rash that appears within hours of a new or increased dose, itching that disturbs sleep, or skin changes that persist through multiple injection cycles should all be discussed. The prescriber may adjust your dose timing, recommend an antihistamine, or decide that Wegovy is not suitable for you to continue. None of those decisions should be made on your own. If itchy eyes have appeared alongside skin symptoms, the connection between Wegovy and eye symptoms is worth understanding too.

The January 2026 MHRA Drug Safety Update on GLP-1 medicines focused primarily on pancreatitis risk, but skin and hypersensitivity reactions are documented in the product's Summary of Product Characteristics. Suspected reactions of any kind can be reported at the MHRA Yellow Card scheme.

Other reasons your skin might itch on Wegovy

Not every itch during Wegovy treatment is caused directly by semaglutide itself. Appetite suppression means some people eat and drink significantly less than before, and dehydration (even mild) is a well-known cause of generalised dry, itchy skin. If the itch is diffuse rather than localised, not especially raised or inflamed, and you have been drinking less than usual, simply increasing your water intake across the day is a sensible first step.

Rapid changes in body weight can also affect the skin: as fat tissue reduces, the skin adjusts, and some people notice increased sensitivity or dryness in areas where there has been significant change. This is not harmful, but it can be uncomfortable and may improve with a fragrance-free moisturiser applied regularly.

It is also worth considering whether anything else changed around the same time as starting Wegovy, a new washing powder, a different fabric, a seasonal allergen, or another medicine introduced at consultation. Separating the timeline helps both you and your prescriber identify the actual trigger. Our dedicated page on semaglutide and itching walks through these contributing factors in more detail. If you are also curious about how the medicine itself is stored and handled (since incorrect temperature can affect a pen's integrity) the guide to semaglutide temperature and storage is a practical reference.

Talking to your prescriber, and how nume approaches ongoing care

The decision about whether to continue Wegovy, pause it, or change your dose in response to skin symptoms belongs to your prescriber, not to a symptom-checker or a forum thread. That is not a legal disclaimer so much as a practical one: the prescriber knows your full clinical picture, your current dose, and your history in a way that generic advice cannot replicate.

At nume, every repeat order is clinically reviewed before it is approved. A real clinician reads your update, not software sorting a queue. If a skin reaction has developed since your last order, noting it during that review process means it is seen and considered, not filed away. Aftercare is available seven days a week. You can reach the team through our contact page. For questions about what is included in treatment and what support looks like day to day, the FAQs set it out plainly.

Wegovy is a prescription-only medicine. Clinical assessment determines suitability, and that suitability can change. The Wegovy overview covers the broader picture of how treatment works and what to expect. If you are considering starting, our free consultation connects you with a GPhC-registered prescriber who can assess whether it is right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions